Preparation of monoclonal antibodies to bovine virus diarrhea virus (BVDV) yielded some hybridoma cells that secreted monoclonal antibodies against the Madin-Darby bovine kidney cells. The anti-cellular monoclonal antibodies reacted with other bovine cells (bovine turbinate and testicle) but not with cell lines derived from other animal species. Subclones derived from one hybridoma partially blocked the infectivity of BVDV, possibly through the binding of the monoclonal antibodies with an epitope close to the receptor site of BVDV and not by way of steric hindrance. Unexpectedly, these same subclones completely blocked the infectivity of bovine enterovirus-3 (BEV-3) strain 240A and partially blocked the infectivity of BEV-2 and BEV-3 (ATCC strain) but not that of other serotypes. Other subclones derived from two other hybridomas, although cell membrane specific, did not have a protective activity against BEV or BVDV.
Bovine virus diarrhea virus (BVDV) is a member of the family Togaviridae and of the genus Pestivirus, which also includes hog cholera virus and the Border disease virus of sheep. The purification of nonarboviruses presents problems which are not encountered with the nonenveloped viruses (for a review, see reference 6) . Qualitative evaluation of the degree of purity of BVDV has shown that cellular components of similar size and density cosediment with the virus (R. Magar and J. Lecomte, J. Virol. Methods, in press).
In the course of production of monoclonal antibodies against purified BVDV, anti-cellular monoclonal antibodies were produced. These were further analyzed to find antireceptor antibodies. BVDV was grown in Madin-Darby bovine kidney (MDBK) cells without serum to minimize exogenous contaminants and was purified through a 25 to 40% (wt/wt) sucrose gradient. Only fractions of 1.13 to 1.14 g/ml were collected and used to immunize BALB/c mice intraperitoneally with 107 50% tissue culture infective doses (TCID50s) in Freund complete adjuvant followed by the same dose in incomplete Freund adjuvant 1 week later. A final booster dose of 107 TCID50s was given intravenously 40 days later. Spleens were removed 3 days after the last injection, and lymphocytes were fused with the P3-X63-653 myeloma cells (7) in the presence of polyethylene glycol (8 Fig. 1 . On acetone-fixed MDBK cells, A4E10 formed a dense network at the intracellular boundaries (Fig. 1A) , whereas C7C8 had a similar reaction pattern (Fig. 1B) but which was more diffused, and C7A5 had a punctate reaction pattern (Fig. 1C) . On fixed bovine turbinate cells, similar reactions were visualized with A4E10 ( Fig. 1D ) and C7C8 ( Fig. 1E ) but appeared to be less abundant, and C7A5 ( Since all antibodies reacted with an antigen expressed on the surface of bovine cells, we next evaluated their protective activity against infection of MDBK cells with BVDV and other viruses. The criteria for selection of these viruses were that they could grow readily on MDBK cells without preadaptation and that each virus had a clear pattern of cytopathogenicity. Undiluted hybridoma culture fluid (50 ,ul) was added to confluent monolayers of MDBK cells in microtiter plates. After e Other viruses were infectious bovine rhinotracheitis virus (Colorado strain, cloned and uncloned), bovine adenovirus-1 and -3, bovine parvovirus, bovine parainfluenza virus 3, and bovine enterovirus (BEV-2 strain 261 and BEV4 strain 165). These latter two strains were obtained from T. Moll and were described by Dunne et al. (5) .
later found to contain neutralizing antibodies to BVDV to a titer of 1/16 against 100 TCID50s/50 ,ul. Rabbit antiserum produced against MDBK cells tested at 1/100 partially blocked the infectivity of BVDV. Unexpectedly, the C7-derived monoclonal antibodies inhibited the infectivity of BEV-3 strain 240A (Table 1) but not the infectivity of BEV-2 strain 261 and BEV-4 strain 165 (data not shown).
To distinguish the neutralizing activity of anti-BVDV in FBS contained in cloned hybridoma culture fluid from the partial blocking activity of the C7-derived monoclonal antibodies against 100 TCID50s of BVDV per 50 ,ul, monoclonal antibodies in hybridoma culture fluid were added undiluted to confluent monolayers of MDBK cells in quadruplicate for 1 h, and the cells were washed and challenged with dilutions of BVDV. Figure 2 shows that the C7-derived monoclonal antibodies had a partial protective activity against challenge by BVDV, by greater than 10-fold the reduction of cytopathogenicity obtained with controls, myeloma culture fluid 653, and culture medium. The apparent blocking activity of A4 and A2 was due to the FBS contained in the hybridoma culture fluid since a similar level of protection was observed with myeloma culture fluid 653 and culture medium containing 10% FBS. Three C7-derived monoclonal antibodies, A4, A2, and myeloma culture fluid 653, were produced in ascitic fluid, and partial protection of cytopathogenicity was also obtained (data not shown) only with the C7-derived monoclonal antibodies. These experiments were repeated twice with similar results.
Since complete blocking of 100 TCID50s of BEV-3 strain 240A per 50 ,ul was obtained, undiluted monoclonal antibodies were added to MDBK cells for 1 h, and the cells were washed and challenged with dilutions of all the serotypes of BEV obtained from the American Type Culture Collection, Rockville, Md. Table 2 shows that the C7-derived monoclonal antibodies had a complete cell-protective activity against the BEV-3 strain 240A challenge. On the other hand, BEV-2 and BEV-3 (ATCC strain) were partially blocked by the C7-derived monoclonal antibodies. From these results, the BEV-3 strain 240A and BEV-3 (ATCC strain) are different, and the latter could be grouped with BEV-2. However, rabbit sera have an inhibitory activity on BEV-2 but not on BEV-3 (ATCC strain). Moll and Ulrich (10) have reported a similar inhibitory activity of normal rabbit serum against BEV serotypes. BEV-1 and BEV-7 could also be grouped together.
The data presented here support the view that the C7-derived monoclonal antibodies are directed against the binding site for the attachment of one strain of bovine enteroviruses to MDBK, since preincubation of MDBK cells with these antibodies prevented the infection by this virus and preincubation with the virus did not preclude the infectivity (data not shown) of MDBK cells. Enteroviruses belong to one of the four genera grouped into the Picornaviridae family. The results of earlier studies, reviewed by Crowell and Landau (4), revealed that there are specific receptors for the different genera and species of picornaviruses. Since then, monoclonal antibodies have been produced against receptor sites on HeLa cells which have been shown to be specific for the three immunotypes of poliovirus (9, 11) , for group B coxsackie viruses (1, 3) , and for human rhinoviruses (2, 13). All these previous studies have dealt with human picornaviruses. However, unlike the human picornaviruses, the group of bovine enteroviruses does not appear to share a common receptor or common epitope because C7-derived monoclonal antibodies recognized a binding site on MDBK cells for BEV-3 strain 240A which is not shared by BEV-2 and BEV-3 (ATCC strain) and all the other serotypes. It may 
